Develops DNA sequencing systems for genetic disease research.
Jun 2026Revenue $159M/yrExpenses $292M/yr
No trendCash runway ≈ 1.9 years from Jun 2026
Figures by year
When will Pacific Biosciences of California be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $159M and expenses $292M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $160M | $714M | −$554M |
| Dec 2024 | $154M | $628M | −$474M |
| Dec 2023 | $201M | $535M | −$334M |
| Dec 2022 | $128M | $436M | −$307M |
| Dec 2021 | $131M | $341M | −$210M |
| Dec 2020 | $78.9M | $183M | −$104M |
| Dec 2019 | $90.9M | $191M | −$101M |
| Dec 2018 | $78.6M | $180M | −$101M |
| Dec 2017 | $93.5M | $183M | −$89.8M |
| Dec 2016 | $90.7M | $162M | −$71.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.